Drug makers release safety pledge to 'ensure public confidence' in COVID-19 vaccine process


Companies behind a number of COVID-19 vaccine candidates have released a joint pledge in an effort to "ensure public confidence" in the process.
Johnson & Johnson, Moderna, and Novavax were among the nine drug companies working on potential COVID-19 vaccines whose CEOs signed a joint pledge released on Tuesday, saying that they won't submit for approval until "after demonstrating safety and efficacy through a Phase 3 clinical study that is designed and conducted to meet requirements of expert regulatory authorities such as FDA," also promising to "always make the safety and well-being of vaccinated individuals our top priority," per The Washington Post.
This pledge came amid concerns over cut corners in the vaccine approval process, especially so that a potential candidate could be ready before the presidential election. Sen. Kamala Harris (D-Calif.), Democratic presidential nominee Joe Biden's running mate, told CNN that should a COVID-19 vaccine be approved and distributed prior to the November election, "I would not trust Donald Trump, and it would have to be a credible source of information" deeming it safe and effective.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Centers for Disease Control and Prevention recently told states to prepare to potentially begin distributing a COVID-19 vaccine as soon as November, leading to "heightened concerns that the Trump administration is seeking to rush the distribution of a vaccine," The New York Times wrote. The White House said "any approval will maintain the FDA's gold standard for safety and testing."
The drug companies say they're looking to "help ensure public confidence in the rigorous scientific and regulatory process by which COVID-19 vaccines are evaluated and may ultimately be approved." Previously, The Wall Street Journal reported that this "unusual joint move" would be made, and the Post described the statement as an "extraordinary effort to bolster public faith in a vaccine."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Anne Hillerman's 6 favorite books with Native characters
Feature The author recommends works by Ramona Emerson, Craig Johnson, and more
-
How Zohran Mamdani's NYC mayoral run will change the Democratic Party
Talking Points The candidate poses a challenge to the party's 'dinosaur wing'
-
Book reviews: '1861: The Lost Peace' and 'Murderland: Crime and Bloodlust in the Time of Serial Killers'
Feature How America tried to avoid the Civil War and the link between lead pollution and serial killers
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments